Agios Pharmaceuticals (AGIO) Net Income towards Common Stockholders Growth (5y) (2017 - 2026)
Agios Pharmaceuticals (AGIO) Net Income towards Common Stockholders Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Agios Pharmaceuticals | 2.20 Bn | 1.46 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.72% |
| Dec 31, 2025 | -52.46% |
| Sep 30, 2025 | -39.18% |
| Jun 30, 2025 | -71.16% |
| Mar 31, 2025 | -35.35% |
| Dec 31, 2024 | 1.98% |
| Sep 30, 2024 | 60.79% |
| Jun 30, 2024 | 0.46% |
| Mar 31, 2024 | -0.11% |
| Dec 31, 2023 | 27.61% |
| Sep 30, 2023 | 1.15% |
| Jun 30, 2023 | -4.81% |
| Mar 31, 2023 | 1.41% |
| Dec 31, 2021 | 15.66% |
| Sep 30, 2021 | 40.96% |
| Jun 30, 2021 | 42.80% |
| Mar 31, 2021 | 144.13% |
| Dec 31, 2020 | 20.24% |
| Sep 30, 2020 | 13.23% |
| Jun 30, 2020 | 22.39% |